Increasing age in essential hypertension was associated with a higher prevalence of left ventricular hypertrophy (63.6% in elderly vs 29.4% in young) and a four-fold higher likelihood of severe LVH.
Cross-Sectional (n=3,752)
No
Does age correlate with the prevalence of severe left ventricular hypertrophy in essential hypertensive patients?
Severe left ventricular hypertrophy is highly prevalent in essential hypertensives, particularly the elderly, suggesting that grading LVH may improve cardiovascular risk assessment.
Absolute Event Rate: 63.6% vs 29.4%
AIM: We sought to investigate the prevalence and correlates of severe left ventricular hypertrophy (LVH) in relation to age in a large cohort of essential hypertensives referred to a single outpatient hypertension clinic. METHODS: A total of 3752 (mean age 53±13 years, 53% men) untreated (29.5%) and treated hypertensive patients categorized in three age groups (I: 18-40 years; II: 41-64 years; III: ≥65 years) were considered for this analysis. All patients underwent extensive investigations searching for target organ damage. LVH, defined as LV mass ≥49/45 g/m(2.7) in men/women, respectively, was graded as mild, moderate and severe according to Lang's report. RESULTS: LVH prevalence was 29.4% in group I, 48.2% in group II and 63.6% in group III. Overall, more than one fourth of patients with LVH had a severely increased LV mass index; the likelihood of having severe LVH was two- and four-fold higher in elderly hypertensives than in their middle-aged and young counterparts, respectively. Increasing age and LVH degree were both associated with a greater prevalence of concentric LV geometry as well as of extra-cardiac organ damage (i.e. carotid intima-media thickness). CONCLUSIONS: LVH is a highly prevalent organ damage in essential hypertensives, particularly in the elderly, who exhibited a more severe increase of LV mass index, higher relative wall thickness and extra-cardiac organ damage compared with young and middle-aged sub-groups. Our findings suggest that the assessment of cardiovascular risk by grading LVH rather than simply defining the presence/absence of this cardiac phenotype could improve therapeutic strategies in the hypertensive population, particularly in the elderly.
Cuspidi et al. (2012) conducted a cross-sectional in Essential hypertension (n=3,752). Increasing age vs. Young age (18-40 years) was evaluated on Prevalence of left ventricular hypertrophy (LVH). Increasing age in essential hypertension was associated with a higher prevalence of left ventricular hypertrophy (63.6% in elderly vs 29.4% in young) and a four-fold higher likelihood of severe LVH.